TokenPost topic

Tarlatamab

1 TokenPost story is tagged Tarlatamab. The newest appear first.

Latest Tarlatamab stories

• Amgen Reports 58% Lower Death Hazard in Lung Cancer Trial

  Median overall survival was 21.1 months with tarlatamab and durvalumab, compared with 12.7 months with durvalumab alone. The trial tested the combination as maintenance therapy after initial treatment.

  Oct 24, 2026, 3:26 PM EDT · Business